Tenaya Therapeutics

About:

Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.

Website: http://www.tenayatherapeutics.com/

Twitter/X: TenayaThera

Top Investors: RA Capital Management, Fidelity, Google Ventures, RTW Investments, T. Rowe Price

Description:

Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease. The company's therapies address heart failure through multipronged efforts that target the fundamental cellular pathologies present in diseased cardiac muscle and that leverage cutting-edge research in cardiac development and regeneration, enabling physicians to regenerate heart tissue, and additional programs focused on cardiomyopathies.

Total Funding Amount:

$373M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2016-01-01

Contact Email:

media(AT)tenayathera.com

Founders:

Benoit Bruneau, Bruce Conklin, Deepak Srivastava, Eric Olson, Saptarsi Haldar, Sheng Ding

Number of Employees:

101-250

Last Funding Date:

2024-02-08

IPO Status:

Public

© 2025 bioDAO.ai